Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 2 2014
Print

Breaking News

August 29, 2014
PODRAS platform technology aims to prevent overdose  Read More »
August 28, 2014
Ullman replaces Matthews  Read More »
August 28, 2014
Initiates Phase II trial of AVP-786 in major depressive disorder  Read More »
August 27, 2014
Training center to aid biopharma companies with manufacturing challenges   Read More »
August 27, 2014
Desai brings 30 years of pharma experience  Read More »
August 27, 2014
Patheon gains biologic sites in St. Louis and Princeton  Read More »
August 26, 2014
Will house finishing ops, inspection services, storage and larger lab  Read More »
August 26, 2014
Hureau brings 25 years of financial experience  Read More »
August 26, 2014
Johns to lead new unit dedicated to development of novel ALS therapies  Read More »
August 26, 2014
Recipharm Venture Fund invests $1.15 million in Isofol  Read More »
August 25, 2014
Expands technologies for closure liner and seal manufacturing  Read More »
August 25, 2014
To supply AMITIZA in global markets  Read More »
August 25, 2014
Phase 1/2 trial to evaluate ADXS-PSA and pembrolizumab in prostate cancer  Read More »
August 25, 2014
Expands respiratory portfolio globally  Read More »
August 21, 2014
Karaboutis to drive technology initiatives  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On